Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to -$62.4 million.

  • Prestige Consumer Healthcare's Enterprise Value fell 2260.29% to -$62.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$62.4 million, marking a year-over-year decrease of 2260.29%. This contributed to the annual value of -$97.9 million for FY2025, which is 11064.37% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Enterprise Value stood at -$62.4 million for Q4 2025, which was down 2260.29% from -$119.1 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Enterprise Value registered a high of -$21.0 million during Q4 2021, and its lowest value of -$163.6 million during Q2 2021.
  • Moreover, its 5-year median value for Enterprise Value was -$53.1 million (2023), whereas its average is -$64.5 million.
  • Examining YoY changes over the last 5 years, Prestige Consumer Healthcare's Enterprise Value showed a top increase of 7807.84% in 2022 and a maximum decrease of 31087.64% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Enterprise Value (Quarter) stood at -$21.0 million in 2021, then tumbled by 310.88% to -$86.4 million in 2022, then grew by 26.34% to -$63.6 million in 2023, then increased by 20.03% to -$50.9 million in 2024, then fell by 22.6% to -$62.4 million in 2025.
  • Its Enterprise Value stands at -$62.4 million for Q4 2025, versus -$119.1 million for Q3 2025 and -$139.5 million for Q2 2025.